制药中国双月报告

月度报告
其他制药与医疗健康业务
201201

制药中国双月报告1201

date 发布日期:2012-01-01
book 目录
toggle
Editor's Notes
date 发布日期: 2025-12-25
lock
  • Editor's Notes 201201
lock 请购买后查看
toggle
Regulatory & Policies
date 发布日期: 2025-12-24
lock
  • MOH announces progress on public hospitals expenditures control
  • NDRC updates essential drugs tendering system and healthcare reform
  • SFDA ensures essential drugs safety and supply
  • SFDA strengthens control on internet drug selling
lock 请购买后查看
toggle
Market & Industry Dynamics
date 发布日期: 2025-12-24
lock
  • Major therapeutic classes market review
  • Antibiotic control impact
  • SFDA requested recall of Caelyx and Velcade
  • Chinese pharmaceuticals received FDA approval
lock 请购买后查看
toggle
Business & Companies Dynamics
date 发布日期: 2025-12-24
lock
  • BMS and Simcere expand strategic cooperation
  • Simcere launches Iremod for active rheumatoid arthritis
  • AstraZeneca expands local manufacturing
  • Boehringer Ingelheim expands Shanghai factory
  • MSD sets up Asia R&D center in Beijing
  • Global CRO targets China market
lock 请购买后查看
toggle
Research & Development
date 发布日期: 2025-12-24
lock
  • HBV therapeutic vaccine Phase III trial continues
lock 请购买后查看
已发布
未来预定
201201
价格细节
[商品总价] $0
期刊 201201
$0
已选产品
1
总计 $0
立即购买
加入购物车